Recursion to Report First Quarter 2024 Business Updates and Financial Results on May 9
May 02, 2024 08:00 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, May 02, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...
Recursion to Host Public L(earnings) Call on February 27
February 20, 2024 07:59 ET
|
Recursion Pharmaceuticals
SALT LAKE CITY, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, announced today it will provide...